Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amcenestrant vs physician's choice endocrine therapy in advanced breast cancer (AMEERA-3, China)
CTR20200974Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amcenestrant in breast cancer, sponsored by Sanofi. Started Jun 2020; status: terminated.
02
Drugs
amcenestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20200974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200974.